Moleculin highlights Annamycin's non-cardiotoxic profile in CEO segment

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. SPY
3. EL
4. ADI
5. ROST
6. BILL
7. WMT
8. MRK
9. MRNA
10. MRVL

Go back to Moleculin highlights Annamycin's non-cardiotoxic profile in CEO segment
METABASIS THERAPEUT (NASDAQ: MBRX) Delayed: 0.59 +0.02 (3.51%)
Previous Close $0.57    52 Week High $9.58 
Open $0.58    52 Week Low $2.34 
Day High $0.64    P/E N/A 
Day Low $0.55    EPS $-0.34 
Volume 1,069,766